Open AccessAn Open-label, Multicenter Study to Assess the Efficacy and Safety of a Novel Probiotic Blend in Patients With Functional Gastrointestinal Symptoms
Author(s) -
Lucinda A. Harris,
Brooks D. Cash,
Karim Moftah,
Howard Franklin
Publication year - 2021
Publication title -
journal of clinical gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.141
H-Index - 112
eISSN - 1539-2031
pISSN - 0192-0790
DOI - 10.1097/mcg.0000000000001567
Subject(s) - medicine , bloating , clinical endpoint , constipation , diarrhea , adverse effect , abdominal pain , probiotic , gastroenterology , incidence (geometry) , randomized controlled trial , physics , biology , bacteria , optics , genetics
A novel 5-strain (Bl-04, Bi-07, HN019, NCFM, and Lpc-37) probiotic blend was developed and its safety and efficacy were evaluated in patients with functional gastrointestinal (GI) symptoms.